Senate Committee Votes to Increase HRSA Funding, Flat Fund OPA and Chides Drug Manufacturers on 340B Restrictions

US Capitol
A Senate Committee recently approved the FY25 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act.
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Highly Anticipated Bipartisan Senate 340B Overhaul Delayed Ahead of August Recess

The SUSTAIN 340B Act, a bipartisan Senate 340B program overhaul, has been delayed after its planned introduction on Aug. 1.
A long-awaited bipartisan senate bill to overhaul the 340B program will not be introduced prior to the August Congressional recess [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Government, 340B Provider Groups Urge Appeals Court to Reverse Dismissal of Health System’s 340B Whistleblower Lawsuit

Adventist Health System/West's 340B whistleblower lawsuit received four amicus briefs in support of its appeal to the U.S. 9th Circuit Court of Appeals.
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Bill Introduced to Extend 340B Eligibility to Qualifying Hospitals in U.S. Territories

Del. Gregorio Kilili Camacho Sablan (D), the at-large delegate for the Northern Mariana Islands, introduced a 340B eligibility bill for the U.S. territories.
New legislation introduced in the U.S. House of Representatives would extend 340B program eligibility to qualifying hospitals in all five [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rep. Matsui’s 340B PATIENTS Act Picks Up New Co-Sponsors

Four more U.S. House Democrats recently signed on to co-sponsor the 340B PATIENTS Act.
Four more U.S. House Democrats recently signed on to co-sponsor a federal bill (H.R. 7635) that would bar drugmaker restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bipartisan Federal Children’s Healthcare Bill with 340B Reporting Requirements Nears House Vote

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
Federal lawmakers may soon vote on a bipartisan bill to streamline Medicaid enrollment for pediatric providers that would also require [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA, RWC-340B Ramp Up Critiques of ASAP 340B-Backed Bill

AHA and RWC-340B again took aim at the 340B ACCESS Act introduced this spring.
Two major national 340B provider advocacy groups are stepping up their criticisms of the 340B ACCESS Act, arguing that the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Merck, Wisconsin Health System Join 340B Working Table; 300+ Firms Lobbied on 340B in Q2

Merck and Marshfield Clinic Health System have joined the growing list of organizations in the 340B Working Table.
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GOP Lawmaker Grills PBM Execs on 340B Profits During House Oversight Hearing

Rep. Diana Harshbarger said major PBMs “rigged the system” by misusing the 340B program during a recent House committee hearing.
A key Republican lawmaker accused executives of the three largest pharmacy benefit managers (PBMs) of “abusing” the 340B program during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

A Closer Look at Kamala Harris’ Positions on 340B and Other Drug Pricing Issues  

While Kamala Harris has not been deeply involved in 340B matters, she has weighed in support of the program and urged action during various battles with the Trump administration.
Vice President Kamala Harris’ quick rise this week to the top of the likely 2024 Democratic presidential ticket sparked renewed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live